Stanford University
Showing 6,271-6,280 of 7,809 Results
-
Hua Shan
Professor of Pathology
BioDr. Shan specializes in providing blood transfusion and apheresis treatment to patients with diverse medical problems. She has been practicing transfusion medicine for over thirty years. Dr. Shan served as the Medical Director of Transfusion Service at Stanford Medical Center from 2015 to 2026. Dr. Shan has also been leading research and education programs in the fields of transfusion safety, optimizing clinical blood transfusion practice and blood availability.
-
Vikram Shankar, MD
Clinical Instructor, Ophthalmology
BioDr. Shankar, MD, MPH, is a board-certified, fellowship-trained ophthalmologist at the Stanford Health Care Byers Eye Institute. He is also a clinical instructor in the Department of Ophthalmology at Stanford University School of Medicine.
Dr. Shankar’s clinical focus is the medical and surgical care of cataracts and adult glaucoma, including premium lenses and minimally invasive glaucoma surgery (MIGS). Dr. Shankar’s research and professional interests include ophthalmic public health, biomedical devices, and digital health. He has a particular interest in the intersection of entrepreneurship, public health, and ophthalmology, aiming to find innovative solutions that will impact millions of patients.
Dr. Shankar has published research on lung cancer metastasis to the optic nerve, pharmacologic therapies in glaucoma, and surgical outcomes with a novel glaucoma device. He has also delivered presentations nationwide on topics including screening rates for diabetic retinopathy based on insurance type and socioeconomic factors, Medicaid expansion, and health disparities.
Dr. Shankar completed a combined MD/MPH at Washington University in St. Louis School of Medicine. He earned the Albert F. Koetter, MD Scholarship; Dean’s Research Fellowship; and Jonathan Mann Fellowship as a medical student. He completed his ophthalmology residency at the Wills Eye Hospital in Philadelphia, PA. He subsequently completed his fellowship in glaucoma at the Stanford Byers Eye Institute.
Dr. Shankar is the cofounder of a seed-stage ophthalmic medical device startup that aims to improve patient safety and mitigate the environmental impact of eye care worldwide.
Dr. Shankar is a member of the American Academy of Ophthalmology. -
Michael Shanks
Professor of Classics
BioProfessor at Stanford University, Michael Shanks is one of the most original and influential of contemporary archaeologists. He has been at the forefront of archaeological thought and practice since the 1980s, pioneering new ways of understanding and explaining, engaging with Graeco-Roman antiquity and European prehistory, mobilizing remains of the past all around us — instigating changes in archaeology and how we all work with remains of the past. A specialist in long-term perspectives on design and creativity, innovation and social change, he explores connections across the sciences, humanities, and arts in research collaborations and outreach through and beyond the academy, tapping more than $32m of funding over the last 25 years.
Current projects
MS is currently completing four long-running and interrelated projects.
Archaeological history — building scenarios.
Greece and Rome: a new model of antiquity. With Gary Devore. A project concerned with how one might conceive of antiquity as a kind of archaeological prehistory, retold through speculative fabulation. Against conventional narrative is offered a model of ancient lifeworlds conveyed through 45 personae and scenarios. Estimated delivery end of 2026.
Archaeological sites — encountering location.
Against place: a border archaeology. Based on archaeological itineraries in the northern borders of England/Scotland, including prehistoric and Roman field research, this project explores border crossings, trespass and transgression in questioning the character of space and place, site and region. Estimated delivery 2027.
Archaeological praxis — performance design.
Theatre/Archaeology: performing remains. With Mike Pearson. This book sums up 30 years of collaboration with performance artist Mike Pearson. In five portfolios of case studies in performance design they set out a pragmatics and methodology of deep mapping contemporary antiquity and prehistory. Estimated delivery end of 2025.
Archaeological actuality — for the future.
Archaeologies of Nature in Art: from Landscape to Climate Breakdown. With Gabriella Giannachi. This project mobilizes an archaeology of arts practices, from prehistory to contemporary art, to offer action-oriented responses to climate change in a reframing of the concept of nature. Estimated delivery autumn 2025.
The following is part of his continuing exploration of Applied Archaeology — design foresight.
Project Athena: Innovation in and through Learning. With Aisin Corporation led by Kenji Suzuki and in collaboration with Kimihiko Iwamura. Developing learning community and competencies in creative pragmatics — designing and implementing a strategy of corporate culture change. Ongoing 2025 – 2026. -
Lucy Shapiro
Virginia and D. K. Ludwig Professor, Emerita
Current Research and Scholarly InterestsA basic question in developmental biology involves the mechanisms used to generate the three-dimensional organization of a cell from a one-dimensional genetic code. Our goal is to define these mechanisms using both molecular genetics and biochemistry.
-
Eric S.G. Shaqfeh
Lester Levi Carter Professor and Professor of Mechanical Engineering
Current Research and Scholarly InterestsI have over 25 years experience in theoretical and computational research related to complex fluids following my PhD in 1986. This includes work in suspension mechanics of rigid partlcles (rods), solution mechanics of polymers and most recently suspensions of vesicles, capsules and mixtures of these with rigid particles. My research group is internationally known for pioneering work in all these areas.
-
Naima G. Sharaf
Assistant Professor of Biology and, by courtesy, of Structural Biology
Current Research and Scholarly InterestsResearch in the lab bridges biology, microbiology, and immunology to translate lipoprotein research into therapeutics
